Your concern is understandable, and your PCP is correct that this is a recognized pharmacological effect. Let me provide the clinical context.

GLP-1 receptor agonists increase heart rate by approximately 2-4 bpm on average in clinical trials, but individual responses vary considerably. The mechanism involves:

1. Direct sinoatrial node effect: GLP-1 receptors are expressed in the SA node, and GLP-1 RA activation increases the firing rate. This appears to be mediated via cAMP-dependent pathways, similar to how beta-agonists work.
2. Sympathetic activation: GLP-1 RAs may mildly increase sympathetic tone through central nervous system effects.
3. Reduced vagal tone: Some evidence suggests GLP-1 RAs modulate parasympathetic input to the heart.

Your 14 bpm increase is at the higher end of what we see but not unprecedented. In the SUSTAIN-6 trial, semaglutide increased HR by a mean of 2.5 bpm, but the range extended to 10-15+ bpm in some individuals.^[1]

The critical question is: does this matter clinically? Despite the HR increase, SELECT showed a 20% MACE reduction. The net cardiovascular effect is overwhelmingly positive, suggesting that whatever risk the HR increase might confer is more than offset by the metabolic and anti-inflammatory benefits.

^[1] Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834-1844.

I appreciate the thorough pharmacology from the cardiologist above. I'll add some practical clinical perspective.

A resting heart rate of 82 bpm is not abnormal by any clinical standard. The "normal" range is 60-100 bpm. At 82, you are well within physiological bounds. The reason it feels different is because you've adapted to a baseline of 68 over many years, and your body notices the change.

That said, here are situations where I'd be more concerned about GLP-1-related tachycardia:

• Resting HR consistently >100 bpm
• Palpitations, irregular rhythm, or sensation of skipped beats
• Associated symptoms: chest pain, lightheadedness, shortness of breath
• Pre-existing arrhythmia (atrial fibrillation, SVT)
• Concurrent use of other HR-elevating medications (stimulants, decongestants, thyroid hormone excess)

If you're experiencing none of these, your PCP's reassurance is appropriate. The HR increase tends to stabilize after the first few months and may even decrease slightly as your body adapts.

Thank you both. I don't have any of those concerning symptoms — no palpitations, no irregular rhythm, no chest pain. It's purely the number on the watch that's bothering me.

One follow-up: I drink about 3-4 cups of coffee daily. Could caffeine be interacting with the GLP-1 to amplify the HR effect? Or is that unrelated?

Caffeine is a methylxanthine that blocks adenosine receptors, which can independently increase heart rate. At 3-4 cups daily (~300-400 mg caffeine), you're at a dose that could contribute to elevated resting HR, and this effect could be additive with GLP-1 RA-induced tachycardia.

If the HR elevation is bothersome, reducing caffeine intake would be a reasonable first step before making any medication changes. Try stepping down to 1-2 cups daily for 2 weeks and see if your resting HR comes down by 3-5 bpm. Also ensure you're well-hydrated, as dehydration (which can occur on GLP-1 therapy due to reduced intake) elevates HR.